CTA
INSP icon

Carillon Tower Advisers’s Inspire Medical Systems INSP Stock Holding History

Carillon Tower Advisers’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$26.1M Sell
138,839
-61,324
-31% -$10M 0.16% 193
2020
Q3 		$25.8M Buy
200,163
+9,175
+5% +$1.01M 0.34% 93
2020
Q2 		$16.6M Buy
+190,988
New +$14.7M 0.13% 223

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Carillon Tower Advisers's INSP Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Inspire Medical Systems (INSP) stake by 31% in Q4 2020, selling an estimated $10M and leaving 138,839 shares worth $26.1M. The position accounts for 0.16% of the portfolio, ranked #193.

Carillon Tower Advisers first reported a position in INSP in Q2 2020 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold INSP as of Q4 2020.

  • Carillon Tower Advisers held 138,839 shares of Inspire Medical Systems worth $26.1M as of Q4 2020.
  • Carillon Tower Advisers sold 61,324 Inspire Medical Systems shares in Q4 2020, an estimated $10M.
  • Inspire Medical Systems made up 0.16% of Carillon Tower Advisers's portfolio in Q4 2020, its #193 holding.
  • Carillon Tower Advisers first reported a position in Inspire Medical Systems in Q2 2020 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.